Neurostimulants

Acute neurological injury affects thousands of patients each year with significant associated morbidity and mortality. In addition to physical disabilities, these patients often have neurocognitive and behavioral deficits including impaired processing and memory, inattention, depression, anxiety, psychosis, and decreased wakefulness that persist for weeks to months after the initial injury that may impede recovery. Neurostimulants may be beneficial in restoring imbalances in dopaminergic, noradrenergic, cholinergic, and serotonergic systems, promoting cognitive recovery, improving communication skills, and increasing engagement with rehabilitation efforts to optimize patient outcomes.